| 摘要 |
Provided is a crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole showing an X-ray powder diffraction pattern having characteristic peaks at interplanar spacings (d) of 10,06+0,2; 8,70±0,2; 6,57±0,2; 5,59±0,2 and 4,00±0,2 Angstroms. The present invention provides a stable antiulcer drug superior in the absorbability. |
